These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8357777)

  • 1. Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.
    Bril A; Landais L; Gout B
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):233-40. PubMed ID: 8357777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers.
    Démolis JL; Martel C; Funck-Brentano C; Sachse A; Weimann HJ; Jaillon P
    Br J Clin Pharmacol; 1997 Oct; 44(4):403-9. PubMed ID: 9354317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
    Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedisamil: master switch of nature?
    Doggrell SA
    Expert Opin Investig Drugs; 2001 Jan; 10(1):129-38. PubMed ID: 11116286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade?
    Tsuchihashi K; Curtis MJ
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):445-56. PubMed ID: 1720845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats.
    Sarraf G; Barrett TD; Walker MJ
    Br J Pharmacol; 2003 Aug; 139(8):1389-98. PubMed ID: 12922925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles.
    Ohler A; Ravens U
    J Pharmacol Exp Ther; 1994 Aug; 270(2):460-5. PubMed ID: 7520940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.
    Barrett TD; MacLeod BA; Walker MJ
    Br J Pharmacol; 2000 Oct; 131(3):405-14. PubMed ID: 11015289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective IK blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischaemia and reperfusion arrhythmias in rat and rabbit hearts.
    Rees SA; Curtis MJ
    Br J Pharmacol; 1993 Jan; 108(1):139-45. PubMed ID: 8428204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate.
    Rees SA; Curtis MJ
    Circulation; 1993 Jun; 87(6):1979-89. PubMed ID: 8504513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
    Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salutary effect of tedisamil on post-ischemic recovery rat heart: involvement of sarcolemmal (Na,K)-ATPase.
    Dzurba A; Ziegelhöffer A; Okruhlicová L; Vrbjar N; Styk J
    Mol Cell Biochem; 2000 Dec; 215(1-2):129-33. PubMed ID: 11204448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
    Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
    Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.